Global Sorafenib Sales Market Report 2016

Publisher Name :
Date: 08-Sep-2016
No. of pages: 122

Notes:

Sales, means the sales volume of Sorafenib

Revenue, means the sales value of Sorafenib

This report studies sales (consumption) of Sorafenib in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Pfizer

- Allergan

- Alnylam Pharmaceuticals

- Amgen

- Angstrom Pharmaceuticals

- Acceleron Pharma

- Biocon

- Bionomics

- CASI Pharmaceuticals

- Celgene Corporation

- Enzon Pharmaceuticals

- Five Prime Therapeutics

- Fujifilm Kyowa Kirin Biologics

- Genentech

- Genexine

- Hetero Drugs

- ImClone Systems

- Intas Pharmaceuticals

- Kyowa Hakko Kirin

- Levolta Pharmaceuticals

- Mabtech

- Marsala Biotech

- Neumedicines

- Novartis

- Oncobiologics

- Onyx Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Sorafenib in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Sorafenib in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Sorafenib Sales Market Report 2016

Table of Contents
Global Sorafenib Sales Market Report 2016
1 Sorafenib Overview
1.1 Product Overview and Scope of Sorafenib
1.2 Classification of Sorafenib
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Sorafenib
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Sorafenib Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Sorafenib (2011-2021)
1.5.1 Global Sorafenib Sales and Growth Rate (2011-2021)
1.5.2 Global Sorafenib Revenue and Growth Rate (2011-2021)
2 Global Sorafenib Competition by Manufacturers, Type and Application
2.1 Global Sorafenib Market Competition by Manufacturers
2.1.1 Global Sorafenib Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Sorafenib Revenue and Share by Manufacturers (2011-2016)
2.2 Global Sorafenib (Volume and Value) by Type
2.2.1 Global Sorafenib Sales and Market Share by Type (2011-2016)
2.2.2 Global Sorafenib Revenue and Market Share by Type (2011-2016)
2.3 Global Sorafenib (Volume and Value) by Regions
2.3.1 Global Sorafenib Sales and Market Share by Regions (2011-2016)
2.3.2 Global Sorafenib Revenue and Market Share by Regions (2011-2016)
2.4 Global Sorafenib (Volume) by Application
3 USA Sorafenib (Volume, Value and Sales Price)
3.1 USA Sorafenib Sales and Value (2011-2016)
3.1.1 USA Sorafenib Sales and Growth Rate (2011-2016)
3.1.2 USA Sorafenib Revenue and Growth Rate (2011-2016)
3.1.3 USA Sorafenib Sales Price Trend (2011-2016)
3.2 USA Sorafenib Sales and Market Share by Manufacturers
3.3 USA Sorafenib Sales and Market Share by Type
3.4 USA Sorafenib Sales and Market Share by Application
4 China Sorafenib (Volume, Value and Sales Price)
4.1 China Sorafenib Sales and Value (2011-2016)
4.1.1 China Sorafenib Sales and Growth Rate (2011-2016)
4.1.2 China Sorafenib Revenue and Growth Rate (2011-2016)
4.1.3 China Sorafenib Sales Price Trend (2011-2016)
4.2 China Sorafenib Sales and Market Share by Manufacturers
4.3 China Sorafenib Sales and Market Share by Type
4.4 China Sorafenib Sales and Market Share by Application
5 Europe Sorafenib (Volume, Value and Sales Price)
5.1 Europe Sorafenib Sales and Value (2011-2016)
5.1.1 Europe Sorafenib Sales and Growth Rate (2011-2016)
5.1.2 Europe Sorafenib Revenue and Growth Rate (2011-2016)
5.1.3 Europe Sorafenib Sales Price Trend (2011-2016)
5.2 Europe Sorafenib Sales and Market Share by Manufacturers
5.3 Europe Sorafenib Sales and Market Share by Type
5.4 Europe Sorafenib Sales and Market Share by Application
6 Japan Sorafenib (Volume, Value and Sales Price)
6.1 Japan Sorafenib Sales and Value (2011-2016)
6.1.1 Japan Sorafenib Sales and Growth Rate (2011-2016)
6.1.2 Japan Sorafenib Revenue and Growth Rate (2011-2016)
6.1.3 Japan Sorafenib Sales Price Trend (2011-2016)
6.2 Japan Sorafenib Sales and Market Share by Manufacturers
6.3 Japan Sorafenib Sales and Market Share by Type
6.4 Japan Sorafenib Sales and Market Share by Application
7 India Sorafenib (Volume, Value and Sales Price)
7.1 India Sorafenib Sales and Value (2011-2016)
7.1.1 India Sorafenib Sales and Growth Rate (2011-2016)
7.1.2 India Sorafenib Revenue and Growth Rate (2011-2016)
7.1.3 India Sorafenib Sales Price Trend (2011-2016)
7.2 India Sorafenib Sales and Market Share by Manufacturers
7.3 India Sorafenib Sales and Market Share by Type
7.4 India Sorafenib Sales and Market Share by Application
8 Southeast Asia Sorafenib (Volume, Value and Sales Price)
8.1 Southeast Asia Sorafenib Sales and Value (2011-2016)
8.1.1 Southeast Asia Sorafenib Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Sorafenib Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Sorafenib Sales Price Trend (2011-2016)
8.2 Southeast Asia Sorafenib Sales and Market Share by Manufacturers
8.3 Southeast Asia Sorafenib Sales and Market Share by Type
8.4 Southeast Asia Sorafenib Sales and Market Share by Application
9 Global Sorafenib Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Sorafenib Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 122 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Alnylam Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 145 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Amgen
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Aug Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Angstrom Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Acceleron Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Biocon
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma & Healthcare Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Bionomics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 CASI Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Celgene Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Enzon Pharmaceuticals
9.12 Five Prime Therapeutics
9.13 Fujifilm Kyowa Kirin Biologics
9.14 Genentech
9.15 Genexine
9.16 Hetero Drugs
9.17 ImClone Systems
9.18 Intas Pharmaceuticals
9.19 Kyowa Hakko Kirin
9.20 Levolta Pharmaceuticals
9.21 Mabtech
9.22 Marsala Biotech
9.23 Neumedicines
9.24 Novartis
9.25 Oncobiologics
9.26 Onyx Pharmaceuticals
10 Sorafenib Maufacturing Cost Analysis
10.1 Sorafenib Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Sorafenib
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Sorafenib Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Sorafenib Market Forecast (2016-2021)
14.1 Global Sorafenib Sales, Revenue Forecast (2016-2021)
14.2 Global Sorafenib Sales Forecast by Regions (2016-2021)
14.3 Global Sorafenib Sales Forecast by Type (2016-2021)
14.4 Global Sorafenib Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Sorafenib
Table Classification of Sorafenib
Figure Global Sales Market Share of Sorafenib by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Sorafenib
Figure Global Sales Market Share of Sorafenib by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Sorafenib Revenue and Growth Rate (2011-2021)
Figure China Sorafenib Revenue and Growth Rate (2011-2021)
Figure Europe Sorafenib Revenue and Growth Rate (2011-2021)
Figure Japan Sorafenib Revenue and Growth Rate (2011-2021)
Figure India Sorafenib Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Sorafenib Revenue and Growth Rate (2011-2021)
Figure Global Sorafenib Sales and Growth Rate (2011-2021)
Figure Global Sorafenib Revenue and Growth Rate (2011-2021)
Table Global Sorafenib Sales of Key Manufacturers (2011-2016)
Table Global Sorafenib Sales Share by Manufacturers (2011-2016)
Figure 2015 Sorafenib Sales Share by Manufacturers
Figure 2016 Sorafenib Sales Share by Manufacturers
Table Global Sorafenib Revenue by Manufacturers (2011-2016)
Table Global Sorafenib Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Sorafenib Revenue Share by Manufacturers
Table 2016 Global Sorafenib Revenue Share by Manufacturers
Table Global Sorafenib Sales and Market Share by Type (2011-2016)
Table Global Sorafenib Sales Share by Type (2011-2016)
Figure Sales Market Share of Sorafenib by Type (2011-2016)
Figure Global Sorafenib Sales Growth Rate by Type (2011-2016)
Table Global Sorafenib Revenue and Market Share by Type (2011-2016)
Table Global Sorafenib Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Sorafenib by Type (2011-2016)
Figure Global Sorafenib Revenue Growth Rate by Type (2011-2016)
Table Global Sorafenib Sales and Market Share by Regions (2011-2016)
Table Global Sorafenib Sales Share by Regions (2011-2016)
Figure Sales Market Share of Sorafenib by Regions (2011-2016)
Figure Global Sorafenib Sales Growth Rate by Regions (2011-2016)
Table Global Sorafenib Revenue and Market Share by Regions (2011-2016)
Table Global Sorafenib Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Sorafenib by Regions (2011-2016)
Figure Global Sorafenib Revenue Growth Rate by Regions (2011-2016)
Table Global Sorafenib Sales and Market Share by Application (2011-2016)
Table Global Sorafenib Sales Share by Application (2011-2016)
Figure Sales Market Share of Sorafenib by Application (2011-2016)
Figure Global Sorafenib Sales Growth Rate by Application (2011-2016)
Figure USA Sorafenib Sales and Growth Rate (2011-2016)
Figure USA Sorafenib Revenue and Growth Rate (2011-2016)
Figure USA Sorafenib Sales Price Trend (2011-2016)
Table USA Sorafenib Sales by Manufacturers (2011-2016)
Table USA Sorafenib Market Share by Manufacturers (2011-2016)
Table USA Sorafenib Sales by Type (2011-2016)
Table USA Sorafenib Market Share by Type (2011-2016)
Table USA Sorafenib Sales by Application (2011-2016)
Table USA Sorafenib Market Share by Application (2011-2016)
Figure China Sorafenib Sales and Growth Rate (2011-2016)
Figure China Sorafenib Revenue and Growth Rate (2011-2016)
Figure China Sorafenib Sales Price Trend (2011-2016)
Table China Sorafenib Sales by Manufacturers (2011-2016)
Table China Sorafenib Market Share by Manufacturers (2011-2016)
Table China Sorafenib Sales by Type (2011-2016)
Table China Sorafenib Market Share by Type (2011-2016)
Table China Sorafenib Sales by Application (2011-2016)
Table China Sorafenib Market Share by Application (2011-2016)
Figure Europe Sorafenib Sales and Growth Rate (2011-2016)
Figure Europe Sorafenib Revenue and Growth Rate (2011-2016)
Figure Europe Sorafenib Sales Price Trend (2011-2016)
Table Europe Sorafenib Sales by Manufacturers (2011-2016)
Table Europe Sorafenib Market Share by Manufacturers (2011-2016)
Table Europe Sorafenib Sales by Type (2011-2016)
Table Europe Sorafenib Market Share by Type (2011-2016)
Table Europe Sorafenib Sales by Application (2011-2016)
Table Europe Sorafenib Market Share by Application (2011-2016)
Figure Japan Sorafenib Sales and Growth Rate (2011-2016)
Figure Japan Sorafenib Revenue and Growth Rate (2011-2016)
Figure Japan Sorafenib Sales Price Trend (2011-2016)
Table Japan Sorafenib Sales by Manufacturers (2011-2016)
Table Japan Sorafenib Market Share by Manufacturers (2011-2016)
Table Japan Sorafenib Sales by Type (2011-2016)
Table Japan Sorafenib Market Share by Type (2011-2016)
Table Japan Sorafenib Sales by Application (2011-2016)
Table Japan Sorafenib Market Share by Application (2011-2016)
Figure India Sorafenib Sales and Growth Rate (2011-2016)
Figure India Sorafenib Revenue and Growth Rate (2011-2016)
Figure India Sorafenib Sales Price Trend (2011-2016)
Table India Sorafenib Sales by Manufacturers (2011-2016)
Table India Sorafenib Market Share by Manufacturers (2011-2016)
Table India Sorafenib Sales by Type (2011-2016)
Table India Sorafenib Market Share by Type (2011-2016)
Table India Sorafenib Sales by Application (2011-2016)
Table India Sorafenib Market Share by Application (2011-2016)
Figure Southeast Asia Sorafenib Sales and Growth Rate (2011-2016)
Figure Southeast Asia Sorafenib Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Sorafenib Sales Price Trend (2011-2016)
Table Southeast Asia Sorafenib Sales by Manufacturers (2011-2016)
Table Southeast Asia Sorafenib Market Share by Manufacturers (2011-2016)
Table Southeast Asia Sorafenib Sales by Type (2011-2016)
Table Southeast Asia Sorafenib Market Share by Type (2011-2016)
Table Southeast Asia Sorafenib Sales by Application (2011-2016)
Table Southeast Asia Sorafenib Market Share by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Sorafenib Global Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Sorafenib Global Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals Sorafenib Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Sorafenib Global Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Angstrom Pharmaceuticals Sorafenib Global Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Acceleron Pharma Sorafenib Global Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Sorafenib Global Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bionomics Sorafenib Global Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CASI Pharmaceuticals Sorafenib Global Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Corporation Sorafenib Global Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Enzon Pharmaceuticals Sorafenib Global Market Share (2011-2016)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Five Prime Therapeutics Sorafenib Global Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Fujifilm Kyowa Kirin Biologics Sorafenib Global Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Sorafenib Global Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genexine Sorafenib Global Market Share (2011-2016)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hetero Drugs Sorafenib Global Market Share (2011-2016)
Table ImClone Systems Basic Information List
Table ImClone Systems Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ImClone Systems Sorafenib Global Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Intas Pharmaceuticals Sorafenib Global Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Kyowa Hakko Kirin Sorafenib Global Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Levolta Pharmaceuticals Sorafenib Global Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mabtech Sorafenib Global Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Marsala Biotech Sorafenib Global Market Share (2011-2016)
Table Neumedicines Basic Information List
Table Neumedicines Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Neumedicines Sorafenib Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Sorafenib Global Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Oncobiologics Sorafenib Global Market Share (2011-2016)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Onyx Pharmaceuticals Sorafenib Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sorafenib
Figure Manufacturing Process Analysis of Sorafenib
Figure Sorafenib Industrial Chain Analysis
Table Raw Materials Sources of Sorafenib Major Manufacturers in 2015
Table Major Buyers of Sorafenib
Table Distributors/Traders List
Figure Global Sorafenib Sales and Growth Rate Forecast (2016-2021)
Figure Global Sorafenib Revenue and Growth Rate Forecast (2016-2021)
Table Global Sorafenib Sales Forecast by Regions (2016-2021)
Table Global Sorafenib Sales Forecast by Type (2016-2021)
Table Global Sorafenib Sales Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United States Glucosamine Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 124
    Notes: Sales, means the sales volume of Glucosamine Revenue, means the sales value of Glucosamine This report studies sales (consumption) of Glucosamine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - CELLMARK - Cargill - AMPIL - Koyo Chemical - Pharma Base - MAHTANI CHITOSAN - Panvo Organics - Bio-gen Extracts - Wanbury -......
  • United States Ampicillin Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 98
    Notes: Sales, means the sales volume of Ampicillin Revenue, means the sales value of Ampicillin This report studies sales (consumption) of Ampicillin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - DSM - ACS Dobfar - Kopran - Antibioticos - United Laboratories - Shandong Lukang Pharmaceutical - CSPC Pharmaceutical - North China Pharmace......
  • United States Letrozole Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 97
    Notes: Sales, means the sales volume of Letrozole Revenue, means the sales value of Letrozole This report studies sales (consumption) of Letrozole in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Teva - Actavis - Mylan - Fresenius Kabi - Endo - Apotex - Sun Pharma - Hengrui Market Segment by States, covering - Calif......
  • United States Nonsteroidal Anti-inflammatory Drug Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Nonsteroidal Anti-inflammatory Drug Revenue, means the sales value of Nonsteroidal Anti-inflammatory Drug This report studies sales (consumption) of Nonsteroidal Anti-inflammatory Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bayer - Actavis - Teva - Mylan - Pfizer - Novartis - Horizon Pharma......
  • United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug This report studies sales (consumption) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Conatus Pharmaceuticals - Daewoong Pharmaceutical - Galmed Internat......
  • United States Tumor Marker Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 96
    Notes: Sales, means the sales volume of Tumor Marker Revenue, means the sales value of Tumor Marker This report studies sales (consumption) of Tumor Marker in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott - Siemens - Alere - Johnson - BD - Nova - ... Market Segment by States, covering - California - Texas......
  • United States Mildronate Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Mildronate Revenue, means the sales value of Mildronate This report studies sales (consumption) of Mildronate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Psypharm - Latvian company - Jinan Chenghui-shuangda Chemical - Canadian Pharmacy - Grindex company - Slovakia - United Pharmacies - chemBli......
  • United States Argatroban Powder Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 116
    Notes: Sales, means the sales volume of Argatroban Powder Revenue, means the sales value of Argatroban Powder This report studies sales (consumption) of Argatroban Powder in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer, Inc - SANDOZ - GlaxoSmithKline Plc - fresenius-kabi - Eagle Pharmaceuticals, Inc - Mitsubishi Tanabe Pharma - Teva Ph......
  • Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2017
    Published: 22-Feb-2017        Price: US 4000 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Boehringer Ingelheim?......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs